Jeff Williams of PennyPro.com says that Zosano Pharma Corp. (ZSAN) is a play right now thanks to an interesting…

RagingBull · December 15, 2017 at 8:15 AM

   Kyle Dennis of BiotechBreakouts.com says that Summit Therapeutics (SMMT) is worth looking at now ahead of a Phase 2…

RagingBull · December 14, 2017 at 8:30 AM

Kyle Dennis of BiotechBreakouts.com says that Exelixis Inc. (EXEL) is poised to move thanks to late-stage approvals for two different…

RagingBull · December 4, 2017 at 8:15 AM

The backstory: Axovant Sciences Ltd. (AXON) was a company I was avoiding last summer, but that I am looking at…

Kyle Dennis · December 1, 2017 at 8:30 AM

The back story: Marinus Pharmaceuticals (MRNS) saw a positive data release in mid-September, which caused the tock to pop from…

Kyle Dennis · November 30, 2017 at 8:35 AM

Kyle Dennis of BiotechBreakouts.com like Synergy Pharmaceuticals Inc. (SGYP) based on a drug for irritable-bowl syndrome that he thinks has…

RagingBull · November 28, 2017 at 7:15 AM

Kyle Dennis of BiotechBreakouts.com revisited Bellicum Pharmaceuticals (BLCM) on the Raging Bull podcast, because the company has early Phase 1-2…

RagingBull · November 17, 2017 at 7:50 AM

The backstory: Marijuana legalization is becoming a thing. With a bunch of states legalizing cannabis for medicinal use, and a few…

Kyle Dennis · November 16, 2017 at 1:15 PM

Kyle Dennis of BiotechBreakouts.com looked back at Oncosec Medical (ONCS) and Melinta Therapeutics (MLNT) in the Raging Bull podcast, noting…

RagingBull · November 10, 2017 at 8:00 AM

When it comes to technical analysis, I believe that simple tends to be better. That’s why I typically use channel…

Kyle Dennis · November 9, 2017 at 2:51 PM

Kyle Dennis of BiotechBreakouts.com said that Axovant Sciences (AXON) has three Alzheimer’s drug test-data releases coming in January, which is…

RagingBull · November 6, 2017 at 8:25 AM

The set-up: It’s hard to find a sector that isn’t stretched to the moon and giving good trade scenarios right…

Jason Bond · November 1, 2017 at 8:40 AM

With biotechnology having been hammered in the market over the last few weeks, Jeff Bishop of TopStockPicks.com thinks it’s about…

RagingBull · November 1, 2017 at 8:00 AM

The setup: Catalyst Pharmaceuticals (CPRX) has been forecasting a fourth-quarter Phase 3 data release for its drug Firdapse in treatment…

Kyle Dennis · October 31, 2017 at 8:30 AM

The back story: Eiger BioPharmaceuticals Inc. (EIGR) has caught my eye again. In August, I saw a nice opportunity for…

Kyle Dennis · October 30, 2017 at 8:38 AM